Vor Biopharma
Miguel Moreta has a diverse range of work experience in the biopharmaceutical industry. Miguel began their career in 2006 at Charles River Laboratories (Merk) as a Technologist. Miguel then moved to Bristol-Myers Squibb in 2007, where they progressed from an Animal Technician to an Assistant Research Scientist II/Associate Research Scientist I. In 2017, Miguel joined Takeda Oncology as a Research Investigator before transitioning to Cue Biopharma in 2018 as a Principal Associate Scientist. Most recently, they are working at Vor Biopharma as a Scientist since August 2020.
Miguel Moreta completed their Bachelor of Science degree in Accounting at the Catholic University of Santo Domingo from 1996 to 2000. In addition to their degree, they obtained a certification in Surgical Techniques in the laboratory Mouse from The Jackson Laboratory in September 2009.
This person is not in any teams
Vor Biopharma
3 followers
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.